| Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
|---|
| 02/15/2005 | US6855317 Immunological herpes simplex virus antigens and methods for use thereof |
| 02/15/2005 | US6855315 Kits for detecting swine infertility and respiratory syndrome (SIRS) virus |
| 02/10/2005 | WO2005012545A2 Cytomegalovirus gene function and methods for developing antivirals, anti-cmv vaccines, and cmv-based vectors |
| 02/10/2005 | WO2005012535A2 Method for producing life attenuated viruses and use of viral particles thus produced. |
| 02/10/2005 | WO2005012527A1 Synthetic gene encoding human epidermal growth factor 2/neu antigen and uses thereof |
| 02/10/2005 | WO2005011715A1 Viral vectors |
| 02/10/2005 | WO2004111249A3 Protein constructs containing caspase recognition sites |
| 02/10/2005 | WO2003030624A3 Hepatitis a virus nucleotide sequences, recombinant proteins and uses thereof |
| 02/10/2005 | US20050032693 Novel polypeptides, their nucleic acids, and methods for their use in angiogenesis and vascularization |
| 02/10/2005 | US20050032222 Modified viral particles with immunogenic properties and reduced lipid content useful for treating and preventing infectious diseases |
| 02/10/2005 | US20050032214 Cell-specific expression/replication vector |
| 02/10/2005 | US20050032064 Method and device for identifying substances capable of modulating adipocyte differentiation |
| 02/10/2005 | US20050032046 Using immortalized cells which express viral cell surface receptor as diagnostic models for screening viricidal agents; drug screening |
| 02/10/2005 | US20050032044 Lipid and cryoprotectant; gene therapy |
| 02/10/2005 | US20050032041 Using viral protein as diagnostic indicator of infection in grapes; immunodiagnostics |
| 02/10/2005 | US20050032036 Using drug resistant bacterial strains as tools for identifying bactericidal phage; preventing staphylococcus infection |
| 02/10/2005 | US20050031643 Microorganisms for therapy |
| 02/10/2005 | US20050031642 Clonal lentogenic oncolytic strain of Newcastle Disease Virus and hemaglutinin-neuraminidase (HN) gene |
| 02/10/2005 | US20050031636 Papilloma virus capsomere vaccine formulations and methods of use |
| 02/10/2005 | US20050031591 Tumor-specific promotor and use thereof |
| 02/10/2005 | US20050029191 Separation medium, its preparation and its use |
| 02/09/2005 | EP1505153A1 Nucleic acid sequence comprising the rna packaging signal of a group 1 coronavirus and the applications thereof |
| 02/09/2005 | EP1504108A2 Viral vector |
| 02/09/2005 | EP1504107A1 Recombinant fowlpox virus |
| 02/09/2005 | EP1504088A2 Bacteriophages useful for therapy and prophylaxis of bacterial infections |
| 02/09/2005 | EP1504016A2 Use of spliceosome mediated rna trans-splicing to confer cell selective replication to adenoviruses |
| 02/09/2005 | EP1503792A2 Attenuation of metapneumovirus |
| 02/09/2005 | EP0966301B1 Identification of human cytomegalovirus genes involved in down-regulation of mhc class i heavy chain expression |
| 02/09/2005 | CN1578837A Regulated nucleic acid expression system |
| 02/09/2005 | CN1578788A Pharmaceutical compositions, and a method of preparing and isolating said pharmaceutical compositions, and use of said pharmaceutical compositions for prophylactic treatment of lesions and carcinomas |
| 02/09/2005 | CN1578678A Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use |
| 02/09/2005 | CN1188168C Vaccine compsn |
| 02/09/2005 | CN1188167C Method of controlling the qualities of attenuated pox vaccine |
| 02/08/2005 | US6852528 Human and mouse uroplakin II gene transcriptional regulatory elements |
| 02/08/2005 | US6852522 Methods and interferon deficient substrates for the propagation of viruses |
| 02/08/2005 | US6852510 Host cells containing multiple integrating vectors |
| 02/03/2005 | WO2005010173A2 Keratinocyte culturing method and the use thereof |
| 02/03/2005 | WO2005010031A1 Peptides capable of binding to titanium, silver and silicone |
| 02/03/2005 | WO2005009372A2 Marek’s disease virus vaccine |
| 02/03/2005 | WO2004000351A8 Packaged virus-like particles for use as adjuvants: method of preparation and use |
| 02/03/2005 | US20050028226 Vaccinia virus mva-e3L-knockout-mutants and use thereof |
| 02/03/2005 | US20050027104 Antibodies for use in diagnosis, prevention and treatment of autoimmune disease |
| 02/03/2005 | US20050026289 Virus clearance of neoplastic cells from mixed cellular compositions |
| 02/03/2005 | US20050026139 Generating transgenic cell comprising expression vector coding apotosis inducing factor for use in treatment of cell proliferative and viral disorders |
| 02/03/2005 | US20050025747 Containing a priming and boosting composition, each with a non-replicating viral vector, with at least one of them being derived from a fowlpox virus; malaria, tuberculosis |
| 02/03/2005 | CA2532582A1 Keratinocyte culturing method and the use thereof |
| 02/03/2005 | CA2531559A1 Adenoviral e1a/e1b complementing cell line |
| 02/02/2005 | EP1501921A1 Improved viral purification methods |
| 02/02/2005 | EP1501543A1 Use of modified novirhabdoviruses to obtain vaccines |
| 02/02/2005 | EP0891420B1 Processes for the replication of influenza viruses in cell culture, and the influenza viruses obtainable by the process |
| 02/02/2005 | EP0862633B1 Virus protein antigens of the jc virus |
| 02/02/2005 | EP0606437B1 Non-shedding live herpesvirus vaccine |
| 02/02/2005 | CN1575339A Replicons derived from positive strand rna virus genomes useful for the production of heterologous proteins |
| 02/02/2005 | CN1187453C Cell lines for propagation of mutated herpes viruses |
| 02/02/2005 | CN1187095C Encapsulated cells capable of producing viral particles |
| 02/02/2005 | CN1187088C Chimeric flavirirus vaccines |
| 02/01/2005 | US6850316 Methods and apparatus for harvesting vaccine from eggs |
| 02/01/2005 | US6849782 Arabidopsis antisense deoxyhypusine synthase molecule and method of inhibiting deoxyhypusine synthase expression in plants |
| 02/01/2005 | US6849446 Genetic engineering |
| 02/01/2005 | US6849431 Non-B, non-C, non-G hepatitis virus gene, polynucleotide, polypeptide, virus particle, method for isolating virus particle, and method for detecting virus |
| 02/01/2005 | US6849429 Viral pseudo-capsids including assembly agonists and antagonists |
| 02/01/2005 | US6849261 CD4-independent HIV envelope proteins as vaccines and therapeutics |
| 01/27/2005 | WO2005007877A2 Regulatable promoters for synthesis of small hairpin rna |
| 01/27/2005 | WO2005007824A2 Mutants of vaccinia virus as oncolytic agents |
| 01/27/2005 | WO2005007689A1 Alphavirus-based cytomegalovirus vaccines |
| 01/27/2005 | WO2003062400A3 Fiber shaft modifications for efficient targeting |
| 01/27/2005 | US20050019929 Deleted adenovirus vectors and methods of making and administering the same |
| 01/27/2005 | US20050019913 Methods for cultivating cells and propagating viruses |
| 01/27/2005 | US20050019891 Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences and methods for propagating virus |
| 01/27/2005 | US20050019770 Macroporous gel, its preparing and its use |
| 01/27/2005 | US20050019759 Attenuated HIV strains and uses thereof |
| 01/27/2005 | US20050019348 Vaccine using genetic engineered virus; transformated Dna; induce immunology response; veterinary medicine |
| 01/27/2005 | US20050019347 Dna sequences and coding for hepatitis virus antigen |
| 01/27/2005 | US20050019307 Therapy gene against mammary gland cancer; transcription control ; Dna |
| 01/27/2005 | CA2531565A1 Production of poxviruses with adherent or non adherent avian cell lines |
| 01/26/2005 | EP1500699A1 Production of vaccinia virus with adherent or non adherent avian cell lines |
| 01/26/2005 | EP1499713A2 Genomic library of cyanophage s-2l and functional analysis |
| 01/26/2005 | EP1499712A1 Hepatitis b viral variants with reduced susceptibility to nucleoside analogs and uses thereof |
| 01/26/2005 | EP1499348A2 Multi plasmid system for the production of influenza virus |
| 01/26/2005 | EP1129723B1 Combined vaccine against both hav and measle virus and method of producing it |
| 01/26/2005 | EP0769968B1 Retroviral vectors produced by producer cell lines resistant to lysis by human serum |
| 01/26/2005 | CN1570122A Adenovirus vector for idiopathy liver genetherapy and using method |
| 01/26/2005 | CN1570121A Virus vector, cell line, method and production system for high effective production of recombinant adenovirus satellite virus |
| 01/26/2005 | CN1570115A Optimized SARS coronary virus spike protein gene |
| 01/26/2005 | CN1570091A Recombinant 1 type herpes simplex virus and its preparation method and uses |
| 01/25/2005 | US6846670 Expressing heterologous nucleotide sequences in cells; obtain vascular cells, incubate with herpes virus, monitor propagation of virus in central nervous system |
| 01/25/2005 | US6846665 Method of producing a recombinant adeno-associated virus, suitable means for producing the same and use thereof for producing a medicament |
| 01/20/2005 | WO2005005645A1 Negative strand rna virus replicon |
| 01/20/2005 | WO2005005637A2 Herpes simplex virus comprising a genetically modified glycoprotein d |
| 01/20/2005 | WO2005005625A2 Method for inducing hepatitis c virus (hcv) replication in vitro, cells and cell lines enabling robust hcv replication and kit therefor |
| 01/20/2005 | WO2005005614A2 Combined b-cell and t-cell epitopes on vlp for improved vaccines |
| 01/20/2005 | WO2005005610A2 Mutant adeno-associated virus virions and methods of use thereof |
| 01/20/2005 | WO2005005596A2 Characterization of the earliest stages of the severe acute respiratory syndrome (sars) virus and uses thereof |
| 01/20/2005 | WO2005004988A2 Compositions and methods relating to novel compounds and targets thereof |
| 01/20/2005 | WO2005004907A1 Packaged virus-like particles |
| 01/20/2005 | WO2004089983A3 Severe acute respiratory syndrome (sars) causing coronavirus |
| 01/20/2005 | US20050015832 Coding for polyol carriers in plants or fungi in polyols with main chain of 5 to 8 carbons with 6 the ideal such as manniotol |
| 01/20/2005 | US20050014262 Viral expression vector for use as heterologous gene and/or therapeutic protein delivery tools; genetic vaccine |
| 01/20/2005 | US20050014261 Chimaeric phages |
| 01/20/2005 | US20050014136 Modified HCV NS5 |